PlainRecalls
FDA Devices Moderate Class II Ongoing

LAVH, REF BBLV21C

Reported: November 1, 2023 Initiated: September 1, 2023 #Z-0172-2024

Product Description

LAVH, REF BBLV21C

Reason for Recall

During an internal investigation, ACS identified that the components, I.V. Cath (part number 4252535-02) and Adhesive Dermabond (part number DHVM12) were inadvertently subjected to the ACS sterilization process and exposed to EO and higher temperatures than approved by the component manufacturer. As a result, the components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) have higher than specified EO residuals.

Details

Units Affected
18 cases
Distribution
US Nationwide distribution in the states of FL, IA.
Location
Temple Terrace, FL

Frequently Asked Questions

What product was recalled?
LAVH, REF BBLV21C. Recalled by American Contract Systems, Inc.. Units affected: 18 cases.
Why was this product recalled?
During an internal investigation, ACS identified that the components, I.V. Cath (part number 4252535-02) and Adhesive Dermabond (part number DHVM12) were inadvertently subjected to the ACS sterilization process and exposed to EO and higher temperatures than approved by the component manufacturer. As a result, the components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) have higher than specified EO residuals.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 1, 2023. Severity: Moderate. Recall number: Z-0172-2024.